Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
Want to see TRDA full AI Analyst Report?
Entrada Therapeutics Inc (TRDA) Ownership Overview
36.05% Insiders
7.97% Mutual Funds
0.10% Other Institutional Investors
8.24% ETFs
47.65% Public Companies and
Individual Investors
The ownership structure of Entrada Therapeutics Inc (TRDA) stock is a mix of institutional, retail, and individual investors. Approximately 16.31% of the company’s stock is owned by Institutional Investors, 36.05% is owned by Insiders, and 47.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 24, 2025 | xxxxxxxxxxxxx | $261678 | |
Nov 18, 2025 | xxxxxxxxxxxxx | $1760000 | |
Nov 18, 2025 | xxxxxxxxxxxxx | $1760000 | |
Nov 12, 2025 | xxxxxxxxxxxxx | $1351942 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $52147664 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $2540671 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $1460891 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,072,730 | Institution | 13.07% | 73,554,585 | |
| 4,691,392 | Insider | 12.08% | 68,025,184 | |
| 4,056,379 | Insider | 10.45% | 58,817,496 | |
| 4,056,379 | Insider | 10.45% | 58,817,496 | |
| 1,447,672 | Institution | 3.73% | 20,991,244 | |
| 1,221,815 | Institution | 3.15% | 17,716,318 | |
| 1,209,080 | Institution | 3.11% | 17,531,660 | |
| 526,014 | Insider | 1.35% | 7,627,203 | |
| 311,171 | Institution | 0.80% | 4,511,980 | |
| 247,147 | Institution | 0.64% | 3,583,632 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,209,080 | Institution | 3.11% | 17,531,660 | |
| 311,171 | Institution | 0.80% | 4,511,980 | |
| 242,384 | Institution | 0.62% | 3,514,568 | |
| 171,368 | Institution | 0.44% | 2,484,836 | |
| 164,005 | Institution | 0.42% | 2,378,073 | |
| 157,249 | Institution | 0.41% | 2,280,111 | |
| 122,416 | Institution | 0.32% | 1,775,032 | |
| 105,909 | Institution | 0.27% | 1,535,681 | |
| 89,898 | Institution | 0.23% | 1,303,521 | |
| 89,351 | Institution | 0.23% | 1,295,590 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 953,727 | Institution | 2.46% | 12,036,035 | |
| 676,287 | Institution | 1.74% | 9,806,162 | |
| 273,451 | Institution | 0.70% | 3,450,952 | |
| 245,594 | Institution | 0.63% | 3,561,113 | |
| 162,120 | Institution | 0.42% | 2,350,740 | |
| 139,651 | Institution | 0.36% | 1,762,396 | |
| 115,479 | Institution | 0.30% | 1,558,967 | |
| 100,802 | Institution | 0.26% | 1,360,827 | |
| 73,232 | Institution | 0.19% | 988,632 | |
| 67,935 | Institution | 0.17% | 917,123 |
FAQ
Who Owns Entrada Therapeutics Inc (TRDA)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 36.05% is held by insiders, and 47.65% is held by retail investors.
What percentage of Entrada Therapeutics Inc (TRDA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.10% of Entrada Therapeutics Inc (TRDA) stock is held by institutional investors.
What percentage of Entrada Therapeutics Inc (TRDA) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.65% of Entrada Therapeutics Inc (TRDA) stock is held by retail investors.
Who owns the most shares of Entrada Therapeutics Inc (TRDA)?
Felix Baker owns the most shares of Entrada Therapeutics Inc (TRDA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.